Research progress of immune-related pneumonia caused by PD-1/PD-L1 inhibitor / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 627-629, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-863541
ABSTRACT
The incidence of immune-related pneumonia caused by programmed death-1/programmed death ligand-1 inhibitors is low, but the risk is high. Patients with non-small cell lung cancer who have pre-existing lung diseases or have received chest radiotherapy are more likely to develop pneumonia, but their clinical symptoms are not typical, which reduces the survival benefit of patients. Delaying immunotherapy early and rationally using glucocorticoids and immunosuppressants can relieve clinical symptoms and improve prognosis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS